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Effect of Chioroacetic Acids on the Kidneys
by Mary E. Davis*
The effects of dichloroacetate (DCA) and trichloroacetate (TCA) administered in drinking water were
studied. At high concentrations ofeither compound, weight loss, or failure to gain weight, was observed.
Foodconsumption was alsodecreased; both effects were attributedtodecreased waterconsumption. Renal
phosphate-dependent glutaminase activity was increased at the highest concentration, and urinary am-
monia was also increased. These changes indicated renal adaptation to an acid load. DCA, in pharma-
cological doses, impairs glucoenogenesis from lactate in part by decreasing lactate availability. Similar
tendencies were observed in the present studies; however, female rats showed abiphasic response. At lower
DCA concentrations, tissue lactate and plasma glucose concentrations were increased, whereas at higher
concentrations of DCA, the expected decreases were observed.
Introduction
The effects of high, pharmacological doses of dichlo-
roacetate (DCA) have been elucidated in recent years
and are reviewed by Crabb and co-workers (1). DCA
activates the pyruvate dehydrogenase complex, result-
ing in decreased synthesis of glucose from lactate. In
addition, DCA is metabolized in the body, producing
glyoxylate and oxalate. These compounds inhibit other
enzymes, including pyruvate carboxylase and pyruvate
kinase. These additionalmetabolic derangements result
in excessive production of ketone bodies (2). DCA also
decreases blood cholesterol concentrations and has been
used to treat hypercholesterolemia, but its usefulness
for long-term therapy is limited by the development of
peripheral polyneuropathy (3). DCA may still be a use-
ful treatment for acute lactic acidosis.
The toxicity oftrichloroacetate (TCA) has been stud-
ied much less. TCA is used extensively for its ability
to precipitate proteins, primarily in biological research,
but also in dermatology for chemical dermabrasion. The
studies reported here focus on drinking water exposure
to DCA and TCA, in an attempt to determine ifeffects
shown at higher doses, and in in vitro studies, might
occur when DCA or TCA is present in drinking water.
Methods
Male and female rats of Sprague-Dawley ancestry,
supplied by Hilltop Farms, were used in all experi-
ments. The animals were maintained in the central an-
imals facilities on lab chow (Wayne Lab Blox).
DCA was administered in drinking water for 14 days.
The concentrations of DCA used (0, 0.03, 0.125, 0.5,
and 1.875g/L) were chosen toyieldtarget doses of(0,10,
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40, 150, and 600 mg/kg/day). Initially a higher dose, 7.5
g/L, was included. The solutions were made up in re-
agent-gradewater. DuringDCAadministration, thean-
imals were maintained individually in stainless-steel
metabolism cages; bodyweight and food and water con-
sumption were measured daily. Urine was collected on
days 7 and 14; volume, osmolality, and ammonia were
measured. At the end of the treatment, the rats were
etherized, bloodsamplesweretakenfromtheabdominal
aorta, and pieces of liver and kidney were taken and
stored for analyses. Samples to be used for lactate and
pyruvate assays were rapidly frozen using clamps at
liquid nitrogen temperature. Plasmawas separated and
stored frozen for glucose analysis.
Lactate and pyruvate were assayed by reduction and
oxidation, respectively, of nicotinamide adenine dinu-
cleotide (reduced) (NADH) in the presence of lactate
dehydrogenase (4,5). Ammonia was measured as utili-
zation of NADH in the synthesis of glutamate from 2-
oxoglutarate, catalyzed by glutamate dehydrogenase
(6). Hippurate was measured colorimetrically based on
its reaction with dimethylaminobenzaldehyde (7). Glu-
cose was measured colorimetrically with Sigma re-
agents (kit 115) based on the hexokinase and glucose-
6-phosphatase reactions. Phosphate-dependent gluta-
minase (PDG) and phosphate-independent glutaminase
(PIG) activities were measured as described by Cur-
thoys and Lowry (8), except that the glutamate pro-
duced was measured using Witt's method (9), which
uses the nicotinamide adenine dinucleotide (NAD) an-
alog, 3-acetylpyridine, to favor the reverse direction of
the glutamate dehydrogenase reaction. Osmolality was
measured by freezing point depression, using an Os-
mette S osmometer.
For the first TCA study, the compound was admin-
istered by gavage, in doses of 30 and 300 mg/kg, daily
for 7 days. In the next study, TCA was administeredM. E. DAVIS
Table 1. Body weight during dichloroacetate administration in
drinking water to male rats.
Body weight, g
DCA DCA DCA DCA DCA DCA
0.00 0.03 0.13 0.50 1.88 7.50
g/L g/L g/L g/L g/L g/L
Day 0 335a 362 321 334 324 294
SEM 13 5 11 18 9 5
Day 7 346 365 322 340 313 253
SEM 10 9 13 17 17 3
Day 14 365 371 332 355 324 277
SEM 8 8 12 15 13 3
aResults are expressed as grams ofbody weight and are shown as
mean ± SEM offive rats, except for n = 2 for 7.50 g/L.
in drinking water at concentrations of 0.3 and 3 g/L to
yield target doses of24 and 240 mg/kg/day. These rats
were maintained inplastic group cages and were placed
in metabolism cages on days 14 and 21 for urine sam-
pling.
All results are expressed as mean + standard error
ofthe mean. Data were analyzed by ANOVA using the
model appropriate to the experimental design. Statis-
tical analyses were done using SAS software from SAS
Institute Inc., Cary, NC. The criterion for significance
was p < 0.05.
Results and Discussion
Resultsforbodyweightondays0, 7, and 14areshown
in Table 1. The high dose (7.5 g/L) caused weight loss
(17% ofstarting weight by day 4) and was used only in
the first group of males. The effects of dose and day
and the interaction between dose and day,are signifi-
cant. The food consumption data (not shown) mirrorthe
body-weight data. Results for female rats are summa-
rized in Table 2; the 7.5 concentration was not used.
The treatment effect was not significant for females.
The female rats on the highest concentration lost
weight, approximately 5%oftheirstartingweight, over
the first 5days, butthentheyregained thisloss. During
thistime, theirfoodconsumptionwasalsoslightlylower
Table 2. Body weight during dichloroacetate administration to
female rats.
Body weight, g
DCA DCA DCA DCA DCA
0;00 0.03 0.13 0.50 1.88
g/L g/L g/L g/L g/L
Day 0 254a 256 251 249 258
SEM 9 12 11 10 9
Day 7 253 254 259 249 249
SEM 10 11 12 9 7
Day 14 262 262 265 254 256
SEM 9 10 14 9 6
aResults are expressed as grams ofbody weight and are shown as
mean ± SEM of six rats, except n = 7 for 1.88 g/L.
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FIGURE 1. Effect ofdichloroacetate onurine output. Maleratswere
givenwatercontainingDCA in the concentrations (g/L) indicated.
Urine was collected on (-) day 7 and (--) day 14. Results are
expressed inmL and are shown as mean ± SE offive rats, except
n = 2 for the 7.5 g/L concentration.
(17 g for controls vs. 12 g for the 1.8 g/L DCA group).
Water loss from the bottle was monitored in all groups
as an approximation of water consumption. The high-
dose groups consumed less water than did the others.
Lower water consumption would account for the de-
creased food consumption, because rats generally will
not consume dry chow ifwater is not available.
Results for urine output on days 7 and 14 are shown
in Figures 1 (males) and 2 (females). Urine volume was
not significantly affected by DCA treatment in either
sex; however, at higher DCA concentrations urine vol-
umes were somewhat decreased on day 7, and less so
on day 14. This finding is consistent with the pattern of
reduced waterconsumption inthese groups. Osmolality
dataare showninFigures 3 and 4. Formales, the effect
of DCA treatment and the interaction between treat-
ment and day oftreatment were significant; forfemales
no significanteffects were detected. Osmolalityand vol-
ume were inversely related, that is, reductions ofurine
volume were countered by elevations ofurine osmolal-
ity. Takentogether, these resultsindicate thatthe abil-
ity to concentrate urine is not impaired by exposure to
DCA.
Excretion of ammonia in urine was measured as one
index of renal adaptation to the acid load. Results for
day 14 are summarized, for both males and females, in
Table 3. The results are expressed as total ammonia
excreted, on day 14, to account for differences ofurine
volume, andtheresults arenonnalized forbodyweight.
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FIGURE 2. Effect ofdichloroacetate on urine output in female rats.
Rats were given water containing DCA in the concentrations (gI
L) indicated. Urine was collected on (-) day 7 and (--) day 14.
Results are expressed in mL and are shown as mean ± SE ofsix
rats.
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FIGURE 3. Urine osmolality in male rats. Male rats were given
watercontaining DCAinthe concentrations (g/L)indicated. Urine
wascollected on (-) day 7 and (--) day 14. Results areexpressed
as mOsmoles/kg water and are shown as mean ± SE offive rats,
except n = 2 for the 7.5 g/L concentration.
The effect of DCA treatment was significant for the
males, but not for the females. The males showed a
normal concentration-response relationship; however,
for females, a biphasic relationship was observed. Am-
monia is produced in the kidneys by the enzymes phos-
phate dependent and independent glutaminase. PDG is
activated by acidosis (8); increased activity ofthis glu-
taminase increases excretion of ammonium ion. PIG is
identical to glutamyltranspeptidase (10); during aci-
dosis, the glutaminase activity predominates. De-
creased pH oftubular urine favors the glutaminase re-
action. Hippurate, produced during acidosis, activates
PIG (11) by binding to the amino acid site (12). Results
for PIG and PDG activities in kidneys from female rats
are shown in Table 4. The effect ofDCA treatment was
significant for PDG, but not for PIG. Furthermore, the
pattern of the effect is similar to that of ammonia ex-
cretion: a decrease at low DCA concentrations and an
increase at high DCA concentrations. Results for hip-
purate excretion are shown in Figures 5 (males) and 6
(females). The effect of DCA administration was not
significant for either sex, on either day 7 or 14. These
results suggestthatrenalcompensationfortheacid load
posed by DCAadministration is accomplished primarily
by activation of PDG. Hippurate production was not
increased, and so was not able to activate the glutamin-
ase activity of y-glutamyltranspeptidase.
DCA treatment has been reported to activate the
pyruvate dehydrogenase complex in liver and kidney,
among other tissues. Oxalate, a metabolite of DCA,
inhibits pyruvate kinase (which catalyzesthe stepinthe
glycolytic pathway from phosphoenol pyruvate to py-
ruvate) and pyruvate carboxylase (which converts py-
ruvate into oxaloacetate). The net effect of these met-
abolic derangements is to decrease the availability of
gluconeogenic substrates, decrease glucose synthesis,
and increase production ofacetoacetate metabolites (1).
Administration ofhigh doses ofDCA decreases plasma
concentrations ofglucose, lactate, and pyruvate. Tissue
concentrations oflactate and pyruvate, for female rats,
are shown in Tables 5 (liver) and 6 (kidney). Results
were similar for both tissues, and the effect of DCA
treatment was not significant for either. The expected
decrease of liver lactate content was observed, sug-
gesting that the high DCA concentration approaches a
minimally effective dose. The results for liver lactate
are similar to the biphasic response seen with females
for ammonia excretion and renal glutaminase activity.
Preliminary results indicate that renal and hepatic lac-
tate contents are decreased by DCA administration in
male rats. Plasma glucose results are shown for both
males and females in Table 7. The effect ofDCA treat-
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FIGURE 4. Urine osmolality in female rats. Rats were given water
containing DCA in the concentrations (g/L) indicated. Urine was
collected on (-) day 7 and (--) day 14. Results are expressed as
mOsmole/kg water and are shown as mean ± SE of six rats.
Table 3. Ammonia excretion in urine on day 14.
NH4' ,mole/g body weight
DCA DCA DCA DCA DCA DCA
0.00 0.03 0.13 0.50 1.88 7.5
Sex g/L g/L g/L g/L g/L g/L
Males 0.232 0.263 0.694 0.607 0.751 1.186
SEM 0.026 0.096 0.239 0.109 0.277 0.125
n 5 5 5 5 5 2
Females 0.517 0.275 0.365 0.710 0.740 nda
SEM 0.084 0.047 0.094 0.277 0.181
n 6 6 6 6 7
aNot done.
Table 4. Renal glutaminase activities for female rats.
Glutamnate formed, ,umole/min/g kidney weight
DCA DCA DCA DCA DCA
0.00 0.03 0.13 0.50 1.88
g/L g/L g/L g/L g/L
PIG 7.17 5.44 5.29 5.93 5.37
SEM 0.75 0.84 0.88 0.83 1.91
n 5 4 5 5 5
PDG 5.74 4.86 4.51 6.78 7.21
SEM 0.57 0.36 0.82 0.45 0.17
n 5 4 5 5 5
FIGURE 5. Hippurate excretion in male rats. Male rats were given
watercontainingDCA inthe concentrations (g/L)indicated. Urine
was collected on (-)day7and (--) day 14. Results areexpressed
as ,ug/day and are shown as mean ± SE offive rats, except n =
2 for the 7.5 g/L concentration.
ment was not significant for either sex. As with the
lactate results, the values for the high dose reflect the
expected decrease; furthermore, the females exhibited
a biphasic pattern. Further studies are necessary to
confirm this effect and to elucidate the mechanism for
the biphasic response.
The effects of TCA administration by gavage are
shown in Figure 7 for body weight and Figure 8 for
food consumption. The low dose, 30 mg/kg, did not alter
eitherbodyweight orfood consumption; theratsgained
weight parallel to the controls, and in general the low-
dose group appeared to be normal. The high-dose (300
mg/kg) group did not fare as well. One rat died on the
second day, and the three survivors, which were hy-
perventilating and cyanotic, were sacrificed onthethird
day. The lungs ofthese rats appeared normal by gross
observation, and the hyperventilation was very likely
respiratory compensation for the acid load (Kussmal
breathing). The initial study on TCA administration in
water was carried out over 3 weeks, with two concen-
trations of TCA. Results for body weight are summa-
rized in Table 8. The effect ofTCA administration was
significant. Althoughthe groups started out atthe same
weights, thehigh-concentrationTCAgroupdidnotgain
weight as rapidly as the others. Food consumption was
not measured in this study; however, it is very likely
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FIGURE 6. Hippurate excretion in female rats. Rats were given
watercontaining DCA intheconcentrations (g/L)indicated. Urine
wascollected on (-) day 7and (--) day 14. Results are expressed
as ,ug/day and are shown as mean ± SE of six rats.
Table 6. Kidney lactate and pyruvate from female rats.
nmole/g wet weight
DCA DCA DCA DCA DCA
0.00 0.03 0.13 0.50 1.88
g/L g/L g/L g/L g/L
Lactate 1300 1240 1320 1270 1060
SEM 200 90 210 260 140
n 6 5 6 6 6
Pyruvate 7 11 7 5 7
SEM 1 3 2 1 2
n 6 5 6 6 7
Ratio 370 170 410 210 180
SEM 200 60 240 70 50
n 6 5 6 5 5
Table 7. Effect of DCA on plasma glucose.
Plasma glucose, mg/100 mL
DCA DCA DCA DCA DCA
0.00 0.03 0.13 0.50 1.88
g/L g/L g/L g/L g/L
Females 190 187 212 174 173
SEM 14 12 27 14 11
n 6 4 3 6 3
Males 188 189 194 190 168
SEM 11 12 14 6 8
n 5 4 4 5 5
thatitwasdecreased inthisgroup. Theresultsforurine
volume and osmolality are summarized in Table 9. The
effects are not significant; however, the group that re-
ceived the high concentration consistently had lower
urine volumesandhigherosmolalities. IntheDCAstud-
ies, results ofthis type were associated with decreased
water consumption; it is very likely that water con-
sumption was decreased in the high-concentration TCA
group. The results forosmolality and urineindicatethat
TCA did not impair urine-concentrating ability.
Table 5. Liver lactate and pyruvate from female rats.
nmole/g wet weight
DCA DCA DCA DCA DCA
0.00 0.03 0.13 0.50 1.88
g/L g/L g/L g/L g/L
Lactate 1550 1260 1860 950 970
SEM 36 100 330 280 100
n 6 6 5 6 7
Pyruvate 15 15 12 11 12
SEM 4 9 6 5 7
n 5 4 5 5 5
Ratio 120 40 8 20 25
SEM 20 0 3 1 11
n 5 2 2 3 5
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FIGURE 7. Effectoftrichloroacetate onbodyweight. Maleratswere
given TCA by gavage daily for 7 days: (-) controls; (--) 30 mg/
kg/day; (- ) 300 mg/kg/day. Results are shown as mean ±
SE offour rats.
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FIGURE 8. Food consumption during trichloroacetic acid adminis-
tration: (-)controls; (--) 30mg/kg/day; (---) 300mg/kg/day.
Results are shown as mean ± SE offour rats.
Table 8. TCA effect on body weight.
Body weight, ga
DCA cone. g/L 0 7 days 14 days 21 days
0 234 258 303 345
SEM 2 3 3 1
0.3 239 258 305 342
SEM 2 3 2 3
3.0 233 248 295 326
SEM 3 4 1 1
aResults are expressed as grams ofbody weight and are shown as
mean ± SEM offour male rats per group.
Table 9. TCA effect on urine volume and osmolality.a
Day 14 Day 21
TCA, g/L Volume, mL mOsmn Volume, mL mOsm
O 9 1877 8 1832
SEM 1 288 1 215
0.3 7 1724 10 1696
SEM 0 87 1 249
3.0 6 2034 6 1964
SEM 1 119 1 129
aResults are shown as mean ± offour male rats per group.
Summary
The studies presented here indicate that subchronic
exposure to DCA, in drinking water, can be associated
with derangements of intermediary metabolism, espe-
cially metabolism oflactate to glucose. Effects on body
weight were observed at higher doses and may repre-
sent refusal to consume water containing the higher
concentrations of DCA or TCA. Exposure to DCA for
14 days in drinking water resulted in changes of am-
moniaexcretionandactivityofenzymesofammoniagen-
esisthat areindicative ofrenal compensation foran acid
load.
Thisresearchwas supported bythe U.S. Environmental Protection
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